CT
RMD icon

Clearstead Trust’s ResMed RMD Stock Holding History

Clearstead Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.7K Buy
52
+26
+100% +$6.48K ﹤0.01% 539
2025
Q4 		$6.26K Buy
26
+15
+136% +$3.84K ﹤0.01% 705
2025
Q3 		$3.01K Hold
11
– – ﹤0.01% 884
2025
Q2 		$2.84K Buy
+11
New +$2.62K ﹤0.01% 868

Other funds holding RMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Clearstead Trust's RMD Position: Q1 2026 in Review

Clearstead Trust increased its ResMed (RMD) stake by 100% in Q1 2026, buying an estimated $6.48K and bringing the position to 52 shares worth $11.7K. The position accounts for ﹤0.01% of the portfolio, ranked #539.

Clearstead Trust first reported a position in RMD in Q2 2025 and has held it in 4 quarters since. 938 funds tracked by Wall St. Rank hold RMD as of Q1 2026.

  • Clearstead Trust held 52 shares of ResMed worth $11.7K as of Q1 2026.
  • Clearstead Trust bought 26 ResMed shares in Q1 2026, an estimated $6.48K.
  • ResMed made up ﹤0.01% of Clearstead Trust's portfolio in Q1 2026, its #539 holding.
  • Clearstead Trust first reported a position in ResMed in Q2 2025 and has held it in 4 quarters since.
  • 938 funds tracked by Wall St. Rank held ResMed as of Q1 2026.

Based on Clearstead Trust's 13F filing for Q1 2026, filed 6 May 2026.